Actos Maker Takeda Facing lawsuit From Patient Diagnosed With Bladder Cancer

A man is alleging he developed bladder cancer after taking Takeda's Actos (pioglitazoe)medication to treat his type 2 diabetes, according to The Madison/St. Clair Record. He has named the Japanese durmaker and its U.S. partner Eli Lilly in the dangerous drugs lawsuit entered into on September 16, 2011. The man claims he took Actos for more than over 12 months beginning in 2007 and received his cancer diagnosis in 2008.

When the man started taking the medication, he was not made aware the drug could increase the risk of developing bladder cancer. This failure to warn is material because Takeda and Lilly appear to have known of the potentially fatal side effect as early as 2005 and did not publish the results of studies indicating the problem.

In June 2011, the U.S. Food and Drug Administration required the increased cancer risk be added to the warnings section of Actos' labeling, and Takeda has recalled the drug in France. 

The man stopped using Actos in 2011. His lawsuit states that because of his use of the drug and his subsequent illness, he experienced extreme pain, and incurred medical costs. His wife alleged she lost his companionship and services.

Takeda and Lilly are accused of negligent failure to warn, negligent design defect, breach of implied warranty, negligence, violation of consumer protection laws, breach of express warranty, negligent misrepresentation, and loss of consortium.

It is sad to learn of a drug's adverse effects.  This firm holds drug manufacturers accountable for dangerous drugs. Contact Shapiro, Lewis & Appleton if you or a loved one suffers injuries from Actos. The firm keeps its cases internally to provide its clients with the convenience and advantages of being represented by a firm that serves VA and NC communities.

LC